Congenital heart malformations, also known as congenital heart defects (CHDs), encompass a spectrum of structural abnormalities in the heart that manifest at birth, originating during fetal development. These defects impact various components of the heart, including its walls, valves, and blood vessels, leading to disruptions in normal blood flow. The severity of CHDs can vary, with some posing minimal health risks while others demand immediate medical attention. The etiology of congenital heart malformations is multifaceted, involving a complex interplay of genetic factors, environmental influences, or a combination thereof. Recent strides in medical technology have revolutionized the landscape of prenatal screening, enabling the early detection of congenital heart malformations. This breakthrough facilitates timely intervention and treatment strategies, ultimately enhancing patient outcomes. Treatment approaches are diverse, tailored to the specific defect and its severity. They range from pharmaceutical interventions to intricate surgical procedures aimed at rectifying the structural anomalies.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation